1. Alanio, A. & Bretagne, S. (2017) Pneumocystis jirovecii detection in asymptomatic patients: what does its natural history tell us? F1000Res., 6, 739.
2. Aletaha, D., Neogi, T., Silman, A.J., Funovits, J., Felson, D.T., Bingham, C.O. 3rd, Birnbaum, N.S., Burmester, G.R., Bykerk, V.P., Cohen, M.D., Combe, B., Costenbader, K.H., Dougados, M., Emery, P., Ferraccioli, G., et al. (2010) 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum., 62, 2569-2581.
3. Chan, E.S. & Cronstein, B.N. (2002) Molecular action of methotrexate in inflammatory diseases. Arthritis Res., 4, 266-273.
4. Chodorowska, G., Czelej, D. & Niewiedziol, M. (2003) Interleukin-2 and its soluble receptor in selected drug-induced cutaneous reactions. Ann. Univ. Mariae Curie Sklodowska Med., 58, 7-13.
5. Genestier, L., Paillot, R., Fournel, S., Ferraro, C., Miossec, P. & Revillard, J.P. (1998) Immunosuppressive properties of methotrexate: apoptosis and clonal deletion of activated peripheral T cells. J. Clin. Invest., 102, 322-328.